Evidence map›Paper›PMID 38138217›Full record

ReviewMedicina (Kaunas, Lithuania)2023

Optical Coherence Tomography (OCT): A Brief Look at the Uses and Technological Evolution of Ophthalmology.

Marco Zeppieri, Stefania Marsili, Ehimare Samuel Enaholo, Ayishetu Oshoke Shuaibu, Ngozi Uwagboe, Carlo Salati, Leopoldo Spadea, Mutali Musa

Abstract readReview
In one paragraph

Review in Medicina (Kaunas, Lithuania), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marco ZeppieriDepartment of Ophthalmology, University Hospital of Udine, 33100 Udine, Italy.ORCID 0000-0003-0999-5545
Stefania MarsiliGeorgia Institute of Technology, School of Biological Sciences, Atlanta, GA 30332, USA.ORCID 0000-0003-0117-8874
Ehimare Samuel EnaholoCentre for Sight Africa, Nkpor, Onitsha 434109, Nigeria.ORCID 0000-0002-2410-7510
Ayishetu Oshoke ShuaibuDepartment of Optometry, University of Benin, Benin City 300238, Nigeria.ORCID 0000-0002-8274-0728
Ngozi UwagboeDepartment of Optometry, University of Benin, Benin City 300238, Nigeria.
Carlo SalatiDepartment of Ophthalmology, University Hospital of Udine, 33100 Udine, Italy.
Leopoldo SpadeaEye Clinic, Policlinico Umberto I, "Sapienza" University of Rome, 00142 Rome, Italy.ORCID 0000-0002-1190-3956
Mutali MusaDepartment of Optometry, University of Benin, Benin City 300238, Nigeria.ORCID 0000-0001-7486-8361

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medical imaging is the mainstay of clinical diagnosis and management. Optical coherence tomography (OCT) is a non-invasive imaging technology that has revolutionized the field of ophthalmology. Since its introduction, OCT has undergone significant improvements in image quality, speed, and resolution, making it an essential diagnostic tool for various ocular pathologies. OCT has not only improved the diagnosis and management of ocular diseases but has also found applications in other fields of medicine. In this manuscript, we provide a brief overview of the history of OCT, its current uses and diagnostic capabilities to assess the posterior segment of the eye, and the evolution of this technology from time-domain (TD) to spectral-domain (SD) and swept-source (SS). This brief review will also discuss the limitations, advantages, disadvantages, and future perspectives of this technology in the field of ophthalmology.

Indexed as

OphthalmologyTomography, Optical CoherenceHumansglaucomaimagingophthalmologyoptical coherence tomography (OCT)retinopathiesspectral-domainswept-sourcetime-domain

Identifiers

PMID38138217
PMCPMC10744394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.